Comments on Draft Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicinces
In January 2008, the Swiss Federal Institute of Intellectual Property submitted its comments on Paul Hunt's draft "Human Rights Guidelines for Pharmaceutical Companies in Relation to Access to Medicines." These comments will be taken into consideration as Mr. Hunt finalizes the Guidelines. To access a copy of this document, please click here.
Swiss Federal Institute of Intellectual Property, "Comments on Draft Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicinces," (2007)
A JOINT PROGRAM OF
